Department of Surgery, Pusan National University College of Medicine, Busan, Korea.
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Head Neck. 2019 Jan;41(1):56-63. doi: 10.1002/hed.25356. Epub 2018 Dec 10.
Recent guidelines advocate unilateral thyroidectomy for low-risk 1-cm to 4-cm differentiated thyroid cancer (DTC). This study was designed to examine the association between the extent of thyroidectomy and oncologic outcomes in patients with 1-cm to 4-cm DTC.
From April 1978 to December 2011, 16 057 patients with DTC underwent thyroidectomy at Yonsei University Hospital. Among them, 5266 (32.8%) patients were classified as having 1-cm to 4-cm DTC and were enrolled in this study. Clinicopathologic features and prognostic results (disease-free survival [DFS] and disease-specific survival [DSS] rates) were analyzed by retrospective medical record review. The mean follow-up duration was 57.3 ± 58.1 months.
Of tumor subtypes in the study group, papillary thyroid carcinoma was the most common (97.5%) and follicular thyroid carcinoma occurred at a rate of 2.5%. In this study, the mean tumor size was 1.84 ± 0.74 cm. Patients had extrathyroidal extension (69.3%), multiplicity (35.1%), bilaterality (26.4%), central lymph node metastasis (53.0%), and lateral neck node metastases (19.9%). Of the 5266 patients, 4292 (81.5%) underwent total thyroidectomy and 974 (18.5%) had lobectomies. Recurrence rates in the total thyroidectomy and lobectomy groups were 5.7% and 9.4%, respectively. The lobectomy group had lower DFS (P = .007) and higher DSS (P = .034) than the total thyroidectomy group. A multivariate analysis for DFS revealed that tumor size, N classification, and extent of thyroidectomy were independent risk factors. On multivariate analysis, independent risk factors for DSS were age, sex, tumor size, and M classifications.
Although extent of thyroidectomy does not affect DSS, total thyroidectomy is beneficial for reducing recurrence in patients with 1-cm to 4-cm DTC. However, if such tumors have such low-risk features as being unifocal, intrathyroidal, and lymph node metastasis-negative, extent of thyroidectomy does not affect oncologic outcome and lobectomy may be sufficient.
最近的指南主张对低危 1 至 4 厘米分化型甲状腺癌(DTC)患者行单侧甲状腺切除术。本研究旨在探讨 1 至 4 厘米 DTC 患者甲状腺切除术范围与肿瘤学结局之间的关系。
1978 年 4 月至 2011 年 12 月,16057 例 DTC 患者在延世大学医院接受甲状腺切除术。其中,5266 例(32.8%)患者被分类为患有 1 至 4 厘米 DTC,并被纳入本研究。通过回顾性病历审查分析临床病理特征和预后结果(无病生存率[DFS]和疾病特异性生存率[DSS])。平均随访时间为 57.3 ± 58.1 个月。
在研究组的肿瘤亚型中,乳头状甲状腺癌最为常见(97.5%),滤泡状甲状腺癌发生率为 2.5%。在本研究中,肿瘤平均大小为 1.84 ± 0.74 厘米。患者存在甲状腺外侵犯(69.3%)、多发病灶(35.1%)、双侧病变(26.4%)、中央淋巴结转移(53.0%)和侧颈部淋巴结转移(19.9%)。在 5266 例患者中,4292 例(81.5%)行甲状腺全切除术,974 例(18.5%)行甲状腺叶切除术。甲状腺全切除术组和甲状腺叶切除术组的复发率分别为 5.7%和 9.4%。甲状腺叶切除术组的 DFS 较低(P =.007),DSS 较高(P =.034)。DFS 的多变量分析显示,肿瘤大小、N 分类和甲状腺切除术范围是独立的危险因素。多变量分析显示,DSS 的独立危险因素为年龄、性别、肿瘤大小和 M 分类。
尽管甲状腺切除术范围不影响 DSS,但甲状腺全切除术有利于降低 1 至 4 厘米 DTC 患者的复发率。然而,如果这些肿瘤具有低危特征,如单发、甲状腺内和淋巴结转移阴性,那么甲状腺切除术范围不影响肿瘤学结果,甲状腺叶切除术可能就足够了。